Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F3TTD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,295
Award facts
- Contract value 100% obligated
- $15,294.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,294.74 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 300 milligram per 2 milliliter Dupixent pens on January 15, 2026, with an ultimate completion date of January 16, 2026. This non-set-aside award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent is a biologic medication commonly prescribed for conditions including eczema, asthma, and chronic rhinosinusitis, and its procurement through the Defense Logistics Agency supports pharmaceutical supply needs across military healthcare systems.
AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal agencies including the Department of Defense and Department of Veterans Affairs. The broader SPE2DX IDC vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military treatment facilities and veteran healthcare programs. This delivery order exemplifies the routine pharmaceutical procurement activity conducted under the larger indefinite delivery framework, allowing the Defense Logistics Agency to obtain essential medications on an as-needed basis at firm fixed prices to support ongoing military medical operations and readiness.
Quick answers
Who was awarded contract SPE2DR26F3TTD?
SPE2DR26F3TTD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F3TTD worth?
The government has obligated $15,295 on SPE2DR26F3TTD.
Is contract SPE2DR26F3TTD an order under another contract?
Yes. SPE2DR26F3TTD is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3TTD competed?
The extent of competition for SPE2DR26F3TTD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award